Literature DB >> 20140726

Seroprevalence of Toxoplasma gondii antibodies in the Slovak Republic.

J Strhársky1, C Klement, F Hrubá.   

Abstract

One-thousand eight-hundreds forty-five individuals were examined for the presence of Toxoplasma gondii antibodies, 31.3 % prevalence of them being found by using the complement fixation test as a screening method. The determined total antibodies were present mainly in low titers which show evidence of past or latent infection. The acute stage of toxoplasmosis by the detection of specific IgM and IgA was diagnosed. The occurrence of acute toxoplasmosis in the healthy population is very low and presents only at 0.3 %. There was no significant difference between genders (p = 0.232), but significant differences in the prevalence of toxoplasmosis depending on age (p < 0.001) and regions (p = 0.007) were found.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140726     DOI: 10.1007/s12223-009-0081-y

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  11 in total

1.  Prevalence of IgM and IgG antibodies to Toxoplasma gondii in blood donors in the Czech Republic.

Authors:  V Svobodová; I Literák
Journal:  Eur J Epidemiol       Date:  1998-12       Impact factor: 8.082

2.  [Toxoplasma gondii].

Authors:  G Catár; D Cerven; N Jalili
Journal:  Bratisl Lek Listy       Date:  1998-11       Impact factor: 1.278

Review 3.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.

Authors:  J M Pinon; H Dumon; C Chemla; J Franck; E Petersen; M Lebech; J Zufferey; M H Bessieres; P Marty; R Holliman; J Johnson; V Luyasu; B Lecolier; E Guy; D H Joynson; A Decoster; G Enders; H Pelloux; E Candolfi
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 5.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

6.  [Toxoplasma gondii antibodies in pregnant women in the Ceské Budĕjovice District].

Authors:  K Hejlícek; I Literák; E Vostalová; J Kresnicka
Journal:  Epidemiol Mikrobiol Imunol       Date:  1999-08       Impact factor: 0.444

7.  Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway.

Authors:  P A Jenum; G Kapperud; B Stray-Pedersen; K K Melby; A Eskild; J Eng
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

8.  Seroprevalence of Toxoplasma gondii antibodies in a healthy population from Slovakia.

Authors:  Carmen Studenicová; Gabriela Bencaiová; Renata Holková
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

9.  The significance of complement fixation test in clinical diagnosis of toxoplasmosis.

Authors:  F Ondriska; G Catar; G Vozarova
Journal:  Bratisl Lek Listy       Date:  2003       Impact factor: 1.278

10.  [Toxoplasma antibody titers in workers with a potentially increased risk for toxoplasma infection].

Authors:  R Nemec; S Necas; R Holková; G Catár; A Porubenová
Journal:  Bratisl Lek Listy       Date:  1988-10       Impact factor: 1.278

View more
  1 in total

1.  The influence of exposure to Toxoplasma Gondii on host lipid metabolism.

Authors:  Fei Xu; Xiwan Lu; Ruitang Cheng; Yuwei Zhu; Sunhan Miao; Qinyi Huang; Yongliang Xu; Liying Qiu; Yonghua Zhou
Journal:  BMC Infect Dis       Date:  2020-06-15       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.